BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 29857523)

  • 21. Ascorbic Acid Reduces the Adverse Effects of Delayed Administration of Tissue Plasminogen Activator in a Rat Stroke Model.
    Allahtavakoli M; Amin F; Esmaeeli-Nadimi A; Shamsizadeh A; Kazemi-Arababadi M; Kennedy D
    Basic Clin Pharmacol Toxicol; 2015 Nov; 117(5):335-9. PubMed ID: 25899606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Strategies to improve post-stroke behavioral recovery in aged subjects.
    Buga AM; Bălşeanu A; Popa-Wagner A; Mogoantă L
    Rom J Morphol Embryol; 2009; 50(4):559-82. PubMed ID: 19942950
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Postischemic intracarotid treatment with TNK-tPA reduces infarct volume and improves neurological deficits in embolic stroke in the unanesthetized rat.
    Zhang RL; Zhang L; Jiang Q; Zhang ZG; Goussev A; Chopp M
    Brain Res; 2000 Sep; 878(1-2):64-71. PubMed ID: 10996136
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination treatment of r-tPA and an optimized human apyrase reduces mortality rate and hemorrhagic transformation 6h after ischemic stroke in aged female rats.
    Tan Z; Li X; Turner RC; Logsdon AF; Lucke-Wold B; DiPasquale K; Jeong SS; Chen R; Huber JD; Rosen CL
    Eur J Pharmacol; 2014 Sep; 738():368-73. PubMed ID: 24933645
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of tissue plasminogen activator timing on blood-brain barrier permeability and hemorrhagic transformation in rats with transient ischemic stroke.
    Zhang Y; Wang Y; Zuo Z; Wang Z; Roy J; Hou Q; Tong E; Hoffmann A; Sperberg E; Bredno J; Berr SS; Xie M; Lee K; Wintermark M
    J Neurol Sci; 2014 Dec; 347(1-2):148-54. PubMed ID: 25292413
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Rho kinase (ROCK) inhibitor, fasudil, prevents matrix metalloproteinase-9-related hemorrhagic transformation in mice treated with tissue plasminogen activator.
    Ishiguro M; Kawasaki K; Suzuki Y; Ishizuka F; Mishiro K; Egashira Y; Ikegaki I; Tsuruma K; Shimazawa M; Yoshimura S; Iwama T; Hara H
    Neuroscience; 2012 Sep; 220():302-12. PubMed ID: 22710066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atorvastatin extends the therapeutic window for tPA to 6 h after the onset of embolic stroke in rats.
    Zhang L; Chopp M; Jia L; Cui Y; Lu M; Zhang ZG
    J Cereb Blood Flow Metab; 2009 Nov; 29(11):1816-24. PubMed ID: 19638998
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Granulocyte-colony stimulating factor inhibits neuronal apoptosis in a rat model of diabetic cerebral ischemia.
    Lan X; Qu H; Yao W; Zhang C
    Tohoku J Exp Med; 2008 Oct; 216(2):117-26. PubMed ID: 18832793
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of tissue plasminogen activator and annexin A2 combination therapy on long-term neurological outcomes of rat focal embolic stroke.
    Wang X; Fan X; Yu Z; Liao Z; Zhao J; Mandeville E; Guo S; Lo EH; Wang X
    Stroke; 2014 Feb; 45(2):619-22. PubMed ID: 24368559
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hydrogen Sulfide Attenuates Tissue Plasminogen Activator-Induced Cerebral Hemorrhage Following Experimental Stroke.
    Liu H; Wang Y; Xiao Y; Hua Z; Cheng J; Jia J
    Transl Stroke Res; 2016 Jun; 7(3):209-19. PubMed ID: 27018013
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early insulin glycemic control combined with tPA thrombolysis reduces acute brain tissue damages in a focal embolic stroke model of diabetic rats.
    Fan X; Ning M; Lo EH; Wang X
    Stroke; 2013 Jan; 44(1):255-9. PubMed ID: 23117722
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of G-CSF treatment on neutrophil mobilization and neurological outcome after transient focal ischemia.
    Strecker JK; Sevimli S; Schilling M; Klocke R; Nikol S; Schneider A; Schäbitz WR
    Exp Neurol; 2010 Mar; 222(1):108-13. PubMed ID: 20026112
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Erythropoietin in combination of tissue plasminogen activator exacerbates brain hemorrhage when treatment is initiated 6 hours after stroke.
    Jia L; Chopp M; Zhang L; Lu M; Zhang Z
    Stroke; 2010 Sep; 41(9):2071-6. PubMed ID: 20671252
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term functional and neurological outcome after simultaneous treatment with tissue-plasminogen activator and hyperbaric oxygen in early phase of embolic stroke in rats.
    Michalski D; Küppers-Tiedt L; Weise C; Laignel F; Härtig W; Raviolo M; Schneider D; Hobohm C
    Brain Res; 2009 Dec; 1303():161-8. PubMed ID: 19766603
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of angiopoietin-1 on hemorrhagic transformation and cerebral edema after tissue plasminogen activator treatment for ischemic stroke in rats.
    Kawamura K; Takahashi T; Kanazawa M; Igarashi H; Nakada T; Nishizawa M; Shimohata T
    PLoS One; 2014; 9(6):e98639. PubMed ID: 24896569
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early use of granulocyte colony stimulating factor improves survival in a rabbit model of chronic myocardial ischemia.
    Zhao Q; Sun C; Xu X; Zhou J; Wu Y; Tian Y; Ma A; Liu Z
    J Cardiol; 2013 Jan; 61(1):87-94. PubMed ID: 23085036
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of factor IX(a) is protective in a rat model of thromboembolic stroke.
    Toomey JR; Valocik RE; Koster PF; Gabriel MA; McVey M; Hart TK; Ohlstein EH; Parsons AA; Barone FC
    Stroke; 2002 Feb; 33(2):578-85. PubMed ID: 11823673
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combining statins with tissue plasminogen activator treatment after experimental and human stroke: a safety study on hemorrhagic transformation.
    Campos M; García-Bonilla L; Hernández-Guillamon M; Barceló V; Morancho A; Quintana M; Rubiera M; Rosell A; Montaner J
    CNS Neurosci Ther; 2013 Nov; 19(11):863-70. PubMed ID: 24118905
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Granulocyte colony-stimulating factor enhances arteriogenesis and ameliorates cerebral damage in a mouse model of ischemic stroke.
    Sugiyama Y; Yagita Y; Oyama N; Terasaki Y; Omura-Matsuoka E; Sasaki T; Kitagawa K
    Stroke; 2011 Mar; 42(3):770-5. PubMed ID: 21257824
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduction of tissue plasminogen activator-induced hemorrhage and brain injury by free radical spin trapping after embolic focal cerebral ischemia in rats.
    Asahi M; Asahi K; Wang X; Lo EH
    J Cereb Blood Flow Metab; 2000 Mar; 20(3):452-7. PubMed ID: 10724108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.